Evidence map›Paper›PMID 24851023›Full record

ArticleJournal of Korean medical science2014

Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution.

Taekmin Kwon, In Gab Jeong, Dalsan You, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim

Open access · goldAbstract read
In one paragraph

Article in Journal of Korean medical science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Taekmin KwonDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID 0000-0003-2280-319X
In Gab JeongDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Dalsan YouDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Bumsik HongDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Jun Hyuk HongDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Hanjong AhnDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Choung-Soo KimDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID 0000-0002-7464-3207
Ulsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate our experience using radical cystectomy to treat patients with bladder cancer and to describe the associations between pathologic features and clinical outcomes. All 701 patients who underwent radical cystectomy for bladder cancer were evaluated. The patient population consisted of 623 men and 78 women. The overall 5 and 10 yr recurrence-free survival (RFS) rates were 61.8% and 57.7%, respectively, and the 5 and 10 yr cancer-specific survival (CSS) rates were 70.8% and 65.1%, respectively. Multivariate analysis showed that factors significantly predictive of RFS and CSS included extravesical extension (P = 0.001), lymph node metastasis (P = 0.001), and lymphovascular invasion (P < 0.001 and P = 0.007). The 5 and 10 yr RFS rates for patients with lymph node metastasis were 25.6% and 20.8%, respectively, and the 5 and 10 yr CSS rates were 38.6% and 30.9%, respectively. Adjuvant chemotherapy significantly improved RFS (P = 0.002) and CSS (P = 0.001) in patients with lymph node metastasis. Radical cystectomy provides good survival results in patients with invasive bladder cancer. Pathologic features significantly associated with prognosis include extravesical extension, node metastasis, and lymphovascular invasion. Adjuvant chemotherapy improves survival in patients with advanced stage disease.

Indexed as

CystectomyChemotherapy, AdjuvantDisease-Free SurvivalFemaleHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessNeoplasm Recurrence, LocalRetrospective StudiesSurvival RateTreatment OutcomeUrinary BladderUrinary Bladder NeoplasmsCystectomyPrognosisUrinary Bladder Neoplasms

Identifiers

PMID24851023
PMCPMC4024950
OpenAlexW2110550490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.